Apellis Pharmaceuticals Inc (APLS)
41.30
-0.70
(-1.67%)
USD |
NASDAQ |
May 17, 16:00
41.30
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals 1 Year Total Returns (Daily): -52.10% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | -52.10% |
May 15, 2024 | -52.42% |
May 14, 2024 | -53.16% |
May 13, 2024 | -51.10% |
May 10, 2024 | -54.05% |
May 09, 2024 | -52.48% |
May 08, 2024 | -53.71% |
May 07, 2024 | -52.89% |
May 06, 2024 | -47.62% |
May 03, 2024 | -44.18% |
May 02, 2024 | -42.88% |
May 01, 2024 | -44.46% |
April 30, 2024 | -47.03% |
April 29, 2024 | -42.66% |
April 26, 2024 | -41.12% |
April 25, 2024 | -45.18% |
April 24, 2024 | -43.75% |
April 23, 2024 | -43.51% |
April 22, 2024 | -44.77% |
April 19, 2024 | -42.11% |
April 18, 2024 | -42.17% |
April 17, 2024 | -41.46% |
April 16, 2024 | -35.99% |
April 15, 2024 | -36.38% |
April 12, 2024 | -35.02% |
Date | Value |
---|---|
April 11, 2024 | -30.03% |
April 10, 2024 | -27.95% |
April 09, 2024 | -30.03% |
April 08, 2024 | -31.70% |
April 05, 2024 | -27.69% |
April 04, 2024 | -28.18% |
April 03, 2024 | -25.73% |
April 02, 2024 | -15.55% |
April 01, 2024 | -9.48% |
March 28, 2024 | -9.54% |
March 27, 2024 | -10.92% |
March 26, 2024 | -6.39% |
March 25, 2024 | -11.90% |
March 22, 2024 | -9.51% |
March 21, 2024 | -8.84% |
March 20, 2024 | -11.94% |
March 19, 2024 | -9.68% |
March 18, 2024 | -10.73% |
March 15, 2024 | -13.41% |
March 14, 2024 | -13.33% |
March 13, 2024 | -8.46% |
March 12, 2024 | -5.98% |
March 11, 2024 | -2.46% |
March 08, 2024 | -4.85% |
March 07, 2024 | -2.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-62.66%
Minimum
Aug 07 2023
230.1%
Maximum
Jan 23 2020
35.28%
Average
25.29%
Median
1 Year Total Returns (Daily) Benchmarks
Inspire Medical Systems Inc | -46.73% |
Sarepta Therapeutics Inc | -11.00% |
Blueprint Medicines Corp | 98.07% |
Alnylam Pharmaceuticals Inc | -20.81% |
Cytokinetics Inc | 60.95% |